nodes	percent_of_prediction	percent_of_DWPC	metapath
Enoxaparin—MPO—Carboplatin—bone cancer	0.483	0.539	CbGbCtD
Enoxaparin—MPO—Cisplatin—bone cancer	0.413	0.461	CbGbCtD
Enoxaparin—Skin necrosis—Cisplatin—bone cancer	0.00425	0.0406	CcSEcCtD
Enoxaparin—Injection site haemorrhage—Epirubicin—bone cancer	0.00283	0.0271	CcSEcCtD
Enoxaparin—Nodule—Methotrexate—bone cancer	0.00277	0.0265	CcSEcCtD
Enoxaparin—Injection site haemorrhage—Doxorubicin—bone cancer	0.00262	0.025	CcSEcCtD
Enoxaparin—Diabetic—Methotrexate—bone cancer	0.00244	0.0233	CcSEcCtD
Enoxaparin—Skin necrosis—Methotrexate—bone cancer	0.00233	0.0223	CcSEcCtD
Enoxaparin—Skin necrosis—Epirubicin—bone cancer	0.00218	0.0209	CcSEcCtD
Enoxaparin—Skin necrosis—Doxorubicin—bone cancer	0.00202	0.0193	CcSEcCtD
Enoxaparin—Pain—Carboplatin—bone cancer	0.00154	0.0148	CcSEcCtD
Enoxaparin—Hepatocellular injury—Cisplatin—bone cancer	0.00149	0.0142	CcSEcCtD
Enoxaparin—Hyperkalaemia—Cisplatin—bone cancer	0.00146	0.0139	CcSEcCtD
Enoxaparin—Osteoporosis—Methotrexate—bone cancer	0.00145	0.0139	CcSEcCtD
Enoxaparin—Body temperature increased—Carboplatin—bone cancer	0.00143	0.0136	CcSEcCtD
Enoxaparin—Skin exfoliation—Cisplatin—bone cancer	0.00142	0.0135	CcSEcCtD
Enoxaparin—Local reaction—Epirubicin—bone cancer	0.00138	0.0132	CcSEcCtD
Enoxaparin—Vesiculobullous rash—Epirubicin—bone cancer	0.00136	0.013	CcSEcCtD
Enoxaparin—Local reaction—Doxorubicin—bone cancer	0.00127	0.0122	CcSEcCtD
Enoxaparin—Vesiculobullous rash—Doxorubicin—bone cancer	0.00126	0.012	CcSEcCtD
Enoxaparin—Thrombocytosis—Epirubicin—bone cancer	0.00123	0.0117	CcSEcCtD
Enoxaparin—Liver disorder—Methotrexate—bone cancer	0.0012	0.0114	CcSEcCtD
Enoxaparin—Paralysis—Methotrexate—bone cancer	0.00117	0.0112	CcSEcCtD
Enoxaparin—Thrombocytosis—Doxorubicin—bone cancer	0.00113	0.0108	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Cisplatin—bone cancer	0.00111	0.0106	CcSEcCtD
Enoxaparin—Paralysis—Epirubicin—bone cancer	0.0011	0.0105	CcSEcCtD
Enoxaparin—Thrombosis—Epirubicin—bone cancer	0.00108	0.0103	CcSEcCtD
Enoxaparin—Hyperlipidaemia—Epirubicin—bone cancer	0.00106	0.0101	CcSEcCtD
Enoxaparin—Dermatitis atopic—Epirubicin—bone cancer	0.00103	0.00984	CcSEcCtD
Enoxaparin—Paralysis—Doxorubicin—bone cancer	0.00102	0.0097	CcSEcCtD
Enoxaparin—Thrombosis—Doxorubicin—bone cancer	0.000997	0.00952	CcSEcCtD
Enoxaparin—Hyperlipidaemia—Doxorubicin—bone cancer	0.000979	0.00935	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000971	0.00927	CcSEcCtD
Enoxaparin—Rash pustular—Epirubicin—bone cancer	0.000956	0.00914	CcSEcCtD
Enoxaparin—Dermatitis atopic—Doxorubicin—bone cancer	0.000953	0.00911	CcSEcCtD
Enoxaparin—Injection site pain—Epirubicin—bone cancer	0.000934	0.00892	CcSEcCtD
Enoxaparin—Rash pustular—Doxorubicin—bone cancer	0.000885	0.00845	CcSEcCtD
Enoxaparin—Injection site pain—Doxorubicin—bone cancer	0.000864	0.00826	CcSEcCtD
Enoxaparin—Inflammation—Methotrexate—bone cancer	0.00084	0.00803	CcSEcCtD
Enoxaparin—Vasculitis—Methotrexate—bone cancer	0.000835	0.00798	CcSEcCtD
Enoxaparin—Myocardial infarction—Cisplatin—bone cancer	0.000814	0.00778	CcSEcCtD
Enoxaparin—Inflammation—Epirubicin—bone cancer	0.000786	0.00751	CcSEcCtD
Enoxaparin—Skin exfoliation—Methotrexate—bone cancer	0.000778	0.00743	CcSEcCtD
Enoxaparin—Hepatocellular injury—Epirubicin—bone cancer	0.000763	0.00729	CcSEcCtD
Enoxaparin—Hyperkalaemia—Epirubicin—bone cancer	0.000749	0.00716	CcSEcCtD
Enoxaparin—Ecchymosis—Methotrexate—bone cancer	0.000737	0.00704	CcSEcCtD
Enoxaparin—Skin exfoliation—Epirubicin—bone cancer	0.000728	0.00696	CcSEcCtD
Enoxaparin—Inflammation—Doxorubicin—bone cancer	0.000727	0.00695	CcSEcCtD
Enoxaparin—Pulmonary oedema—Methotrexate—bone cancer	0.000725	0.00693	CcSEcCtD
Enoxaparin—Hepatocellular injury—Doxorubicin—bone cancer	0.000706	0.00674	CcSEcCtD
Enoxaparin—Hyperkalaemia—Doxorubicin—bone cancer	0.000693	0.00662	CcSEcCtD
Enoxaparin—Ecchymosis—Epirubicin—bone cancer	0.00069	0.00659	CcSEcCtD
Enoxaparin—Diabetes mellitus—Methotrexate—bone cancer	0.00068	0.0065	CcSEcCtD
Enoxaparin—Pulmonary oedema—Epirubicin—bone cancer	0.000679	0.00649	CcSEcCtD
Enoxaparin—Skin exfoliation—Doxorubicin—bone cancer	0.000674	0.00644	CcSEcCtD
Enoxaparin—Alopecia—Cisplatin—bone cancer	0.000659	0.0063	CcSEcCtD
Enoxaparin—Erythema—Cisplatin—bone cancer	0.000649	0.0062	CcSEcCtD
Enoxaparin—Ecchymosis—Doxorubicin—bone cancer	0.000638	0.0061	CcSEcCtD
Enoxaparin—Diabetes mellitus—Epirubicin—bone cancer	0.000636	0.00608	CcSEcCtD
Enoxaparin—Pulmonary oedema—Doxorubicin—bone cancer	0.000628	0.006	CcSEcCtD
Enoxaparin—Vascular purpura—Epirubicin—bone cancer	0.000619	0.00591	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Methotrexate—bone cancer	0.000611	0.00584	CcSEcCtD
Enoxaparin—Anaemia—Cisplatin—bone cancer	0.0006	0.00573	CcSEcCtD
Enoxaparin—Diabetes mellitus—Doxorubicin—bone cancer	0.000589	0.00563	CcSEcCtD
Enoxaparin—Malaise—Cisplatin—bone cancer	0.000585	0.00559	CcSEcCtD
Enoxaparin—Dermatitis bullous—Epirubicin—bone cancer	0.000579	0.00553	CcSEcCtD
Enoxaparin—Purpura—Epirubicin—bone cancer	0.000574	0.00549	CcSEcCtD
Enoxaparin—Vascular purpura—Doxorubicin—bone cancer	0.000573	0.00547	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Epirubicin—bone cancer	0.000572	0.00546	CcSEcCtD
Enoxaparin—Cardiac failure—Epirubicin—bone cancer	0.000567	0.00542	CcSEcCtD
Enoxaparin—Dermatitis bullous—Doxorubicin—bone cancer	0.000536	0.00512	CcSEcCtD
Enoxaparin—Purpura—Doxorubicin—bone cancer	0.000531	0.00508	CcSEcCtD
Enoxaparin—Anaphylactic shock—Cisplatin—bone cancer	0.00053	0.00506	CcSEcCtD
Enoxaparin—Oedema—Cisplatin—bone cancer	0.00053	0.00506	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000529	0.00506	CcSEcCtD
Enoxaparin—Cardiac failure—Doxorubicin—bone cancer	0.000525	0.00501	CcSEcCtD
Enoxaparin—Thrombocytopenia—Cisplatin—bone cancer	0.000519	0.00496	CcSEcCtD
Enoxaparin—Eosinophilia—Methotrexate—bone cancer	0.000506	0.00484	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000498	0.00476	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000488	0.00466	CcSEcCtD
Enoxaparin—Eosinophilia—Epirubicin—bone cancer	0.000474	0.00453	CcSEcCtD
Enoxaparin—Dyspnoea—Cisplatin—bone cancer	0.000472	0.00451	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000461	0.00441	CcSEcCtD
Enoxaparin—Pneumonia—Methotrexate—bone cancer	0.000459	0.00438	CcSEcCtD
Enoxaparin—Pain—Cisplatin—bone cancer	0.000453	0.00433	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000452	0.00432	CcSEcCtD
Enoxaparin—Eosinophilia—Doxorubicin—bone cancer	0.000438	0.00419	CcSEcCtD
Enoxaparin—Feeling abnormal—Cisplatin—bone cancer	0.000437	0.00417	CcSEcCtD
Enoxaparin—Haematuria—Methotrexate—bone cancer	0.000435	0.00415	CcSEcCtD
Enoxaparin—Pneumonia—Epirubicin—bone cancer	0.000429	0.0041	CcSEcCtD
Enoxaparin—Body temperature increased—Cisplatin—bone cancer	0.000419	0.004	CcSEcCtD
Enoxaparin—Haemoglobin—Methotrexate—bone cancer	0.000411	0.00393	CcSEcCtD
Enoxaparin—Haemorrhage—Methotrexate—bone cancer	0.000409	0.00391	CcSEcCtD
Enoxaparin—Haematuria—Epirubicin—bone cancer	0.000407	0.00389	CcSEcCtD
Enoxaparin—Pneumonia—Doxorubicin—bone cancer	0.000397	0.00379	CcSEcCtD
Enoxaparin—Hypersensitivity—Cisplatin—bone cancer	0.00039	0.00373	CcSEcCtD
Enoxaparin—Haemoglobin—Epirubicin—bone cancer	0.000385	0.00368	CcSEcCtD
Enoxaparin—Haemorrhage—Epirubicin—bone cancer	0.000383	0.00366	CcSEcCtD
Enoxaparin—Oedema peripheral—Epirubicin—bone cancer	0.000377	0.0036	CcSEcCtD
Enoxaparin—Haematuria—Doxorubicin—bone cancer	0.000376	0.0036	CcSEcCtD
Enoxaparin—Diarrhoea—Cisplatin—bone cancer	0.000363	0.00346	CcSEcCtD
Enoxaparin—Alopecia—Methotrexate—bone cancer	0.000362	0.00345	CcSEcCtD
Enoxaparin—Erythema—Methotrexate—bone cancer	0.000356	0.0034	CcSEcCtD
Enoxaparin—Haemoglobin—Doxorubicin—bone cancer	0.000356	0.0034	CcSEcCtD
Enoxaparin—Haemorrhage—Doxorubicin—bone cancer	0.000354	0.00339	CcSEcCtD
Enoxaparin—Oedema peripheral—Doxorubicin—bone cancer	0.000349	0.00334	CcSEcCtD
Enoxaparin—Alopecia—Epirubicin—bone cancer	0.000338	0.00323	CcSEcCtD
Enoxaparin—Erythema—Epirubicin—bone cancer	0.000333	0.00319	CcSEcCtD
Enoxaparin—Anaemia—Methotrexate—bone cancer	0.000329	0.00315	CcSEcCtD
Enoxaparin—Malaise—Methotrexate—bone cancer	0.000321	0.00307	CcSEcCtD
Enoxaparin—Nausea—Cisplatin—bone cancer	0.000315	0.00301	CcSEcCtD
Enoxaparin—Alopecia—Doxorubicin—bone cancer	0.000313	0.00299	CcSEcCtD
Enoxaparin—Erythema—Doxorubicin—bone cancer	0.000308	0.00295	CcSEcCtD
Enoxaparin—Anaemia—Epirubicin—bone cancer	0.000308	0.00294	CcSEcCtD
Enoxaparin—Malaise—Epirubicin—bone cancer	0.000301	0.00287	CcSEcCtD
Enoxaparin—Confusional state—Methotrexate—bone cancer	0.000293	0.0028	CcSEcCtD
Enoxaparin—Anaphylactic shock—Methotrexate—bone cancer	0.000291	0.00278	CcSEcCtD
Enoxaparin—Anaemia—Doxorubicin—bone cancer	0.000285	0.00272	CcSEcCtD
Enoxaparin—Thrombocytopenia—Methotrexate—bone cancer	0.000285	0.00272	CcSEcCtD
Enoxaparin—Malaise—Doxorubicin—bone cancer	0.000278	0.00266	CcSEcCtD
Enoxaparin—Confusional state—Epirubicin—bone cancer	0.000274	0.00262	CcSEcCtD
Enoxaparin—Oedema—Epirubicin—bone cancer	0.000272	0.0026	CcSEcCtD
Enoxaparin—Anaphylactic shock—Epirubicin—bone cancer	0.000272	0.0026	CcSEcCtD
Enoxaparin—Shock—Epirubicin—bone cancer	0.000268	0.00256	CcSEcCtD
Enoxaparin—Thrombocytopenia—Epirubicin—bone cancer	0.000266	0.00255	CcSEcCtD
Enoxaparin—Dyspnoea—Methotrexate—bone cancer	0.000259	0.00248	CcSEcCtD
Enoxaparin—Confusional state—Doxorubicin—bone cancer	0.000254	0.00243	CcSEcCtD
Enoxaparin—Anaphylactic shock—Doxorubicin—bone cancer	0.000252	0.00241	CcSEcCtD
Enoxaparin—Oedema—Doxorubicin—bone cancer	0.000252	0.00241	CcSEcCtD
Enoxaparin—Pain—Methotrexate—bone cancer	0.000249	0.00238	CcSEcCtD
Enoxaparin—Shock—Doxorubicin—bone cancer	0.000248	0.00237	CcSEcCtD
Enoxaparin—Thrombocytopenia—Doxorubicin—bone cancer	0.000246	0.00235	CcSEcCtD
Enoxaparin—Dyspnoea—Epirubicin—bone cancer	0.000243	0.00232	CcSEcCtD
Enoxaparin—Feeling abnormal—Methotrexate—bone cancer	0.00024	0.00229	CcSEcCtD
Enoxaparin—Pain—Epirubicin—bone cancer	0.000233	0.00222	CcSEcCtD
Enoxaparin—Urticaria—Methotrexate—bone cancer	0.000231	0.00221	CcSEcCtD
Enoxaparin—Body temperature increased—Methotrexate—bone cancer	0.00023	0.0022	CcSEcCtD
Enoxaparin—Dyspnoea—Doxorubicin—bone cancer	0.000224	0.00214	CcSEcCtD
Enoxaparin—Feeling abnormal—Epirubicin—bone cancer	0.000224	0.00214	CcSEcCtD
Enoxaparin—Urticaria—Epirubicin—bone cancer	0.000216	0.00207	CcSEcCtD
Enoxaparin—Pain—Doxorubicin—bone cancer	0.000215	0.00206	CcSEcCtD
Enoxaparin—Body temperature increased—Epirubicin—bone cancer	0.000215	0.00205	CcSEcCtD
Enoxaparin—Hypersensitivity—Methotrexate—bone cancer	0.000214	0.00205	CcSEcCtD
Enoxaparin—Feeling abnormal—Doxorubicin—bone cancer	0.000207	0.00198	CcSEcCtD
Enoxaparin—Pruritus—Methotrexate—bone cancer	0.000206	0.00197	CcSEcCtD
Enoxaparin—Hypersensitivity—Epirubicin—bone cancer	0.0002	0.00192	CcSEcCtD
Enoxaparin—Urticaria—Doxorubicin—bone cancer	0.0002	0.00191	CcSEcCtD
Enoxaparin—Body temperature increased—Doxorubicin—bone cancer	0.000199	0.0019	CcSEcCtD
Enoxaparin—Diarrhoea—Methotrexate—bone cancer	0.000199	0.0019	CcSEcCtD
Enoxaparin—Pruritus—Epirubicin—bone cancer	0.000192	0.00184	CcSEcCtD
Enoxaparin—Diarrhoea—Epirubicin—bone cancer	0.000186	0.00178	CcSEcCtD
Enoxaparin—Hypersensitivity—Doxorubicin—bone cancer	0.000185	0.00177	CcSEcCtD
Enoxaparin—Headache—Methotrexate—bone cancer	0.000182	0.00174	CcSEcCtD
Enoxaparin—Pruritus—Doxorubicin—bone cancer	0.000178	0.0017	CcSEcCtD
Enoxaparin—Nausea—Methotrexate—bone cancer	0.000173	0.00165	CcSEcCtD
Enoxaparin—Diarrhoea—Doxorubicin—bone cancer	0.000172	0.00165	CcSEcCtD
Enoxaparin—Headache—Epirubicin—bone cancer	0.00017	0.00163	CcSEcCtD
Enoxaparin—Nausea—Epirubicin—bone cancer	0.000162	0.00154	CcSEcCtD
Enoxaparin—Headache—Doxorubicin—bone cancer	0.000158	0.00151	CcSEcCtD
Enoxaparin—Nausea—Doxorubicin—bone cancer	0.00015	0.00143	CcSEcCtD
